Evidence map›Paper›PMID 40718741›Full record

ArticleSudanese journal of paediatrics2025

A diagnostic challenge in Kawasaki disease: a case report.

Kübra Nur Erdoğan, Mustafa Gençeli, Uğur Saraç, Özge Metin Akcan, Ayşe Büşra Paydaş, Fatih Şap

Abstract readCase Reports
In one paragraph

Article in Sudanese journal of paediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A diagnostic challenge in Kawasaki disease: a case report.Sudanese journal of paediatrics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kübra Nur ErdoğanDepartment of Pediatrics, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
Mustafa GençeliDepartment of Pediatric Infectious Diseases, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
Uğur SaraçDepartment of Pediatrics Cardiology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
Özge Metin AkcanDepartment of Pediatric Infectious Diseases, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
Ayşe Büşra PaydaşDepartment of Pediatrics Cardiology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
Fatih ŞapDepartment of Pediatrics Cardiology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kawasaki disease (KD) is characterised by high fever lasting more than 5 days, conjunctivitis, oedema of hands or feet, erythema of the palms and soles, polymorphic rash, cervical lymphadenopathy and alteration of oral mucosa and lips. It is most frequently seen in children between the ages of 6 months and 5 years. The diagnosis of KD remains challenging, primarily due to its incomplete presentation. In this report, we present a 3.5-month-old patient who has persistent fever and bilateral nonpurulent conjunctivitis and high acute phase reactants, diagnosed with incomplete KD and coronary aneurysm. The patient was given intravenous immunoglobulin (IVIG) at 2 g/kg with oral aspirin at 80 mg/kg/d. On follow-up 48 hours later, marked clinical improvement was observed. Monthly cardiac evaluations were performed. Echocardiogram in the 3rd month of treatment showed the internal dimension of the proximal section of the left main coronary artery measuring 3 mm (Z-score = 3.8) and the aneurysm regressed. Even if cases with prolonged fever do not meet the diagnostic criteria for KD, they should be considered as atypical KD and IVIG should be considered.

Indexed as

Coronary aneurysmFeverKawasaki disease

Identifiers

PMID40718741
PMCPMC12288157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.